Peptide and Peptidomimetic Therapeutics

History1. Therapeutic peptides: historical perspectives and current development trends Basic science2. Therapeutic peptidomimetics: targeting the undruggable space3. Tailoring peptides and peptidomimetics for targeting protein-protein interactions4. Advances in peptide synthesis5. Stapled peptidomimetic therapeutics6. Ring closing metathesis Drug discovery7. The current state of backbone cyclic peptidomimetics and their application to drug discovery8. Pharmacokinetics and pharmacodynamics of peptidomimetics9. Formulations of peptides and peptidomimetics10. Cell-penetrating peptides11. Intracellular peptides as drug prototypes12. Applications of computational three-dimensional structure prediction for antimicrobial peptides Therapeutic applications13. Knottin peptidomimetics as therapeutics14. Venom peptidomimetics as therapeutics15. Therapeutic peptides targeting protein kinase: progress, challenges and future directions, featuring cancer and cardiovascular disease16. Therapeutic peptidomimetics for infectious diseases17. Antiparasitic therapeutic peptidomimetics18. Peptides and antibiotic resistance19. Antimicrobial peptides and the skin and gut microbiomes20. Peptide and peptidomimetic based vaccines21. Therapeutic peptidomimetics for cancer treatment22. Immunomodulatory peptidomimetics for multiple sclerosis therapy - the story of glatiramer acetate (Copaxone)23. Therapeutic peptidomimetics in metabolic diseases24. Therapeutic peptidomimetics in anesthesiology25. Cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease26. Non-cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease Drug development27. Clinical and preclinical data on therapeutic peptides28. Therapeutic peptides: manufacturing and market29. Future perspectives on peptide therapeutics